Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 5
2004 3
2005 9
2006 11
2007 12
2008 21
2009 20
2010 13
2011 14
2012 12
2013 17
2014 16
2015 11
2016 30
2017 41
2018 39
2019 40
2020 33
2021 51
2022 42
2023 36
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

409 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean zonggui he (12 results)?
Emerging role of natural products in cancer immunotherapy.
Dong S, Guo X, Han F, He Z, Wang Y. Dong S, et al. Among authors: he z. Acta Pharm Sin B. 2022 Mar;12(3):1163-1185. doi: 10.1016/j.apsb.2021.08.020. Epub 2021 Aug 21. Acta Pharm Sin B. 2022. PMID: 35530162 Free PMC article. Review.
Inflammatory microenvironment-targeted nanotherapies.
Zhang G, Ma L, Bai L, Li M, Guo T, Tian B, He Z, Fu Q. Zhang G, et al. Among authors: he z. J Control Release. 2021 Jun 10;334:114-126. doi: 10.1016/j.jconrel.2021.04.018. Epub 2021 Apr 20. J Control Release. 2021. PMID: 33887284 Review.
Nanotherapeutics for Antimetastatic Treatment.
Yang F, Zhao Z, Sun B, Chen Q, Sun J, He Z, Luo C. Yang F, et al. Among authors: he z. Trends Cancer. 2020 Aug;6(8):645-659. doi: 10.1016/j.trecan.2020.05.001. Epub 2020 May 21. Trends Cancer. 2020. PMID: 32448754 Review.
Recent advances in SN-38 drug delivery system.
Yang J, Jia L, He Z, Wang Y. Yang J, et al. Among authors: he z. Int J Pharm. 2023 Apr 25;637:122886. doi: 10.1016/j.ijpharm.2023.122886. Epub 2023 Mar 24. Int J Pharm. 2023. PMID: 36966982 Review.
Smart Nanogatekeepers for Tumor Theranostics.
Zhang X, Chen Y, He X, Zhang Y, Zhou M, Peng C, He Z, Gui S, Li Z. Zhang X, et al. Among authors: he z. Small. 2021 Nov;17(47):e2103712. doi: 10.1002/smll.202103712. Epub 2021 Oct 22. Small. 2021. PMID: 34677898 Review.
Emerging nanotaxanes for cancer therapy.
Zhang Y, Zhang W, Wang Y, Zhu J, Zhou M, Peng C, He Z, Sun J, Li Z, Gui S. Zhang Y, et al. Among authors: he z. Biomaterials. 2021 May;272:120790. doi: 10.1016/j.biomaterials.2021.120790. Epub 2021 Apr 1. Biomaterials. 2021. PMID: 33836293 Review.
Emerging nanotherapeutics for antithrombotic treatment.
Zhao Z, Yang F, Zhang X, Sun J, He Z, Luo C. Zhao Z, et al. Among authors: he z. Biomaterials. 2020 Oct;255:120200. doi: 10.1016/j.biomaterials.2020.120200. Epub 2020 Jun 12. Biomaterials. 2020. PMID: 32563945 Review.
Lymph node-targeting nanovaccines for cancer immunotherapy.
Wang Q, Wang Z, Sun X, Jiang Q, Sun B, He Z, Zhang S, Luo C, Sun J. Wang Q, et al. Among authors: he z. J Control Release. 2022 Nov;351:102-122. doi: 10.1016/j.jconrel.2022.09.015. Epub 2022 Sep 20. J Control Release. 2022. PMID: 36115556 Review.
409 results